<DOC>
	<DOCNO>NCT01543282</DOCNO>
	<brief_summary>This randomize control study compare EUS-FNA 22 gauge 25 gauge needle consecutive patient . Summary Background : three needle size endoscopic ultrasonography guide fine needle aspiration ( EUS-FNA ) currently available : 22 Gauge ( G ) , 25 G 19 G. However , well design study compare regard efficacy feasibility lack . Aims : investigate diagnostic yield , specimen adequacy , feasibility complication conventional 22 G compare 25 G needle . Methods : patient ≥ 18 year , refer EUS-FNA solid lesion consider inclusion . Patients suspect diagnosis lymphoma , GIST , sarcoidosis , significant coagulopathy ( APT &lt; 50 % platelet &lt; 50000/mm3 ) , use warfarin anticoagulant , use clopidogrel within 7 day EUS , inability refusal sign inform consent pregnancy suspect pregnancy exclude . Participants randomize 22 G needle 25 G FNA . Chi-square test use compare proportion . Continuous variable compare use Student´s test . A two-tailed P value less 0.05 consider statistically significant . The diagnostic yield 25 G 22 G needle evaluate four criterion : sensitivity , specificity , positive predictive value negative predictive value . An expected rate 85 % diagnostic yield EUS guide FNA use 22G needle consider . By use power 80 % α value 0.05 would necessary 120 patient per group detect 15 % difference rate diagnostic yield .</brief_summary>
	<brief_title>Endoscopic Ultrasonography ( EUS ) Guided Fine Needle Aspiration Using Free Stylet 22g 25 g Needles</brief_title>
	<detailed_description>1 . Objectives PRIMARY To compare diagnostic yield stylet-free , solid lesion EUS-FNA use 22 G FNA vs 25 G FNA needle , consecutive patient refer EUS-FNA . SECONDARY To investigate : 1. specimen adequacy , 2. number FNA pass , 3. ease puncture , 4. failure FNA needle 5. complication 3 . Methods 3.1 . Design : prospective randomize trial . 3.2 . Inclusion : Consecutive patient refer EUS-FNA solid lesion consider inclusion . 3.3 . Exclusion : Age &lt; 18 year , patient suspect diagnosis lymphoma , GIST , sarcoidosis lesion large amount tissue require diagnosis , significant coagulopathy ( INR &gt; 1.5 , platelet &lt; 50000/mm3 , use low molecular weight heparin , use clopidogrel within 7 day EUS ) , cystic lesion , inability refusal sign inform consent . 3.4 . Endoscopic procedure : Informed consent obtain procedure one researcher . Patients receive economic compensation reimbursement expense come exploration , since procedure previously indicate . Then , potential candidate randomize 22 G 25 G FNA use computer generate random sequence . There block randomization ) pancreatic mass , 2 ) lymph node , 3 ) lesion . All examination perform two experienced endosonographers lineal echoendoscope ( AS SP ) . EUS procedure carry patient , leave lateral position conscious sedation use midazolam ( 2.5-5 mg ) plus meperidine ( 50-100 mg ) droperidol ( 2.5-5 mg ) . Before perform EUS-FNA biopsy , complete examination pancreas , liver well vicinity organ perform . EUS-FNA pass perform without stylet sample adequacy maximum 5 FNA pass pancreatic lesion 3 FNA pass lesion . In case inadequate sample 3 pass , needle failure , cross type needle allow . Ease puncture score qualitatively poor ( scored 1 ) , good ( scored 2 ) excellent ( scored 3 ) . [ 14 ] FNA failure also report . All procedure digitally videotape . The examination review endosonographer blind type needle use visibility needle score ( score 1 `` poor '' , score 2 `` good '' , score 3 `` excellent '' ) . [ 14 ] After procedure , patient monitor recovery room least 60 minute discharge . Immediate complication assess record nurse and/or physician procedure patient recover sedation . 3.5 . Cytological analysis : All pass read one experienced cytopathologist on-site utilizing microscopic evaluation air-dried slide stain Diff-Quik ( International Reagents Co. , Ltd. , Kobe , Japan ) . The cytopathologist blind type needle use . The final cytological diagnosis make use standard Papanicolaou stain . For lesion , cytologist assess sample adequacy : cellularity ( score 1 `` poor '' , score 2 `` good '' , score 3 `` excellent '' ) , [ 14 ] bloodiness ( score 1 `` minimal '' , score 2 `` moderate '' , score 3 `` significant '' ) [ 21 ] presence absence malignancy ( `` positive '' / '' negative '' / '' suspicious '' / inconclusive ) . 3.6 . Follow Lesions consider malignant following case : positive cytological diagnosis , positive histological diagnosis clinical radiological progression next 6 month . In case negative result cytological diagnosis absence clinical worsen radiologic progression least follow 6 month FNA require . 3.7 . Data collection Clinical data prospectively collect saved database include : demographic information ( age gender ) , size location target lesion ( pancreas , lymph node , liver , adrenal gland , others ) technical procedure variable : FNA path ( esophagus , stomach , duodenum ) , number needle pass , needle visibility , ease puncture , needle failure , cellularity , bloodiness , cytological diagnosis , final diagnosis , immediate complication . 4 . Statistical analysis Results continuous variable express mean standard deviation . Categorical variable express frequency percentage . Chi-square test use compare proportion . Continuous variable compare use Student´s test . A two-tailed P value less 0.05 consider statistically significant . Data analyze Statistical Package Social Sciences v. 15.0 ( SPSS Inc. , Chicago , IL , USA ) . The diagnostic yield 15 G 22 G needle evaluate four criterion : sensitivity , specificity , positive predictive value negative predictive value . Sample size An expect rate diagnostic yield EUS guide FNA use 22G needle 85 % consider . By use power 80 % α value 0.05 would necessary 120 patient per group detect 15 % difference rate diagnostic yield .</detailed_description>
	<criteria>Consecutive patient refer EUSFNA solid lesion . Age &lt; 18 year Patients suspect diagnosis lymphoma , GIST , sarcoidosis lesion large amount tissue require diagnosis Significant coagulopathy ( INR &gt; 1.5 , platelet &lt; 50000/mm3 Use low molecular weight heparin , use clopidogrel within 7 day EUS ) Cystic lesion Inability refusal sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>endoscopic ultrasonography</keyword>
	<keyword>fine needle aspiration cytology</keyword>
	<keyword>22 gauge</keyword>
	<keyword>25 gauge</keyword>
</DOC>